Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Carol Mansfield, Lubomyra Nalysnyk, Dhaivat Joshi, Joshua Coulter & Ruth Pulikottil-Jacob. (2023) Impact of Potential Symptoms and Risks Associated with Acid Sphingomyelinase Deficiency on Patients and Caregivers: A Best-Worst Scaling Study. Patient Preference and Adherence 17, pages 927-939.
Read now
Read now
A. Brett Hauber, Engels N. Obi, Mark A. Price, Diane Whalley & Chun-Lan Chang. (2017) Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure. Current Medical Research and Opinion 33:11, pages 2027-2038.
Read now
Read now
Ji-Hye Byun, Sun-Hong Kwon, Ji-Hye Ha & Eui-Kyung Lee. (2016) A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients. Therapeutics and Clinical Risk Management 12, pages 965-974.
Read now
Read now
Articles from other publishers (22)
Chloë Laferrière, Chloé Moazzami, Emilie Belley-Côté, Kevin R. Bainey, Guillaume Marquis-Gravel, Alexa Fama, Marie Lordkipanidzé & Brian J. Potter. (2023) Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making. CJC Open.
Crossref
Crossref
Tommi Tervonen, Thibaud Prawitz, Gin Nie Chua, Johanna Hyacinthe & Cathy Anne Pinto. (2022) Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment. Journal of Clinical Epidemiology 144, pages 84-92.
Crossref
Crossref
Guoxing Zuo, Ying Li, Sheng Hu, Kuan Wang, Hui Zhao, Dong Wang, Xiaoqian Qian & Xinping Du. (2022) The efficacy of the use of heparin in the emergency room in patients with acute ST-segment elevation myocardial infarction. Journal of Radiation Research and Applied Sciences 15:1, pages 187-192.
Crossref
Crossref
Cathy Anne Pinto, Gin Nie Chua, John F. P. Bridges, Ella Brookes, Johanna Hyacinthe & Tommi Tervonen. (2021) Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment. The Patient - Patient-Centered Outcomes Research 15:2, pages 255-266.
Crossref
Crossref
Tommi Tervonen, Pareen Vora, Jaein Seo, Nicolas Krucien, Kevin Marsh, Raffaele De Caterina, Ulrike Wissinger & Montse Soriano Gabarró. (2021) Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis. The Patient - Patient-Centered Outcomes Research 14:5, pages 661-672.
Crossref
Crossref
Debraj Das, Anamaria Savu, Kevin R. Bainey, Robert C. Welsh & Padma Kaul. (2021) Temporal Trends in in-Hospital Bleeding and Transfusion in a Contemporary Canadian ST-Elevation Myocardial Infarction Patient Population. CJC Open 3:4, pages 479-487.
Crossref
Crossref
Scott R Evans, Mikael Knutsson, Pierre Amarenco, Gregory W Albers, Philip M Bath, Hans Denison, Per Ladenvall, Jenny Jonasson, J Donald Easton, Kazuo Minematsu, Carlos A Molina, Yongjun Wang, KS Lawrence Wong & S Claiborne Johnston. (2020) Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial. Clinical Trials 17:6, pages 617-626.
Crossref
Crossref
D. Turk, M. Boeri, L. Abraham, J. Atkinson, A.G. Bushmakin, J.C. Cappelleri, B. Hauber, K. Klein, L. Russo, L. Viktrup & D. Walsh. (2020) Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Osteoarthritis and Cartilage 28:9, pages 1202-1213.
Crossref
Crossref
Bennett Levitan, Rachael L. DiSantostefano & Scott Evans. 2019. Pharmacoepidemiology. Pharmacoepidemiology
867
896
.
Noa Dagan, Chandra J. Cohen-Stavi, Meytal Avgil Tsadok, Morton Leibowitz, Moshe Hoshen, Tomas Karpati, Amichay Akriv, Ilan Gofer, Harel Gilutz, Eduardo Podjarny, Eitan Bachmat & Ran D. Balicer. (2019) Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views. npj Digital Medicine 2:1.
Crossref
Crossref
Zachary R. Dionise, Juan Marcos Gonzalez, Michael L. Garcia-Roig, Andrew J. Kirsch, Charles D. ScalesJrJr, John S. Wiener, J. Todd Purves & Jonathan C. Routh. (2019) Parental Preferences for Vesicoureteral Reflux Treatment: A Crowd-sourced, Best-worst Scaling Study. Urology 128, pages 71-77.
Crossref
Crossref
Juan Marcos Gonzalez. (2019) A Guide to Measuring and Interpreting Attribute Importance. The Patient - Patient-Centered Outcomes Research 12:3, pages 287-295.
Crossref
Crossref
Carol Mansfield, Briana Ndife, Joyce Chen, Kathleen Gallaher & Sameer Ghate. (2019) Patient preferences for treatment of metastatic melanoma. Future Oncology 15:11, pages 1255-1268.
Crossref
Crossref
Charles Reynard, Niall Morris, Phil Moss, Heather Jarman & Richard Body. (2019) Optimising antiplatelet utilisation in the acute care setting: a novel threshold for medical intervention in suspected acute coronary syndromes. Emergency Medicine Journal 36:3, pages 163-170.
Crossref
Crossref
Juhaeri Juhaeri. (2019) Benefit–risk evaluation: the past, present and future. Therapeutic Advances in Drug Safety 10, pages 204209861987118.
Crossref
Crossref
M. Elaine Husni, Anthony Fernandez, Brett Hauber, Rakesh Singh, Joshua Posner, Jessie Sutphin & Arijit Ganguli. (2018) Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Etienne Dantan, Yohann Foucher, Marine Lorent, Magali Giral & Philippe Tessier. (2016) Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine. Statistical Methods in Medical Research 27:6, pages 1847-1859.
Crossref
Crossref
Kimberly H. Davis, Jun Su, Juan Marcos González, Jeremiah J. Trudeau, Lauren M. Nelson, Brett Hauber & Kelly A. Hollis. (2017) Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref
Axel C. Mühlbacher, Anika Kaczynski, Peter Zweifel & F. Reed Johnson. (2016) Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview. Health Economics Review 6:1.
Crossref
Crossref
Kei Long Cheung, Ben F. M. Wijnen, Ilene L. Hollin, Ellen M. Janssen, John F. Bridges, Silvia M. A. A. Evers & Mickael Hiligsmann. (2016) Using Best–Worst Scaling to Investigate Preferences in Health Care. PharmacoEconomics 34:12, pages 1195-1209.
Crossref
Crossref
Philip S. Wells, Martin H. Prins, Bennett Levitan, Jan Beyer-Westendorf, Timothy A. Brighton, Henri Bounameaux, Alexander T. Cohen, Bruce L. Davidson, Paolo Prandoni, Gary E. Raskob, Zhong Yuan, Eva G. Katz, Martin Gebel & Anthonie W.A. Lensing. (2016) Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE. Chest 150:5, pages 1059-1068.
Crossref
Crossref
Eleftherios Mamounas, Christine Poulos, Hans-Peter Goertz, Juan Marcos González, Amy Pugh & Vincent Antao. (2016) Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals. Annals of Surgical Oncology 23:11, pages 3510-3517.
Crossref
Crossref